Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
布伦妥昔单抗治疗复发/难治性生殖细胞肿瘤的II期临床试验
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-021-01134-1
Ashkar, Ryan; Feldman, Darren R; Adra, Nabil; Zaid, Mohammad Abu; Funt, Samuel A; Althouse, Sandra K; Perkins, Susan M; Snow, Christin I; Lazzara, Kayla M; Sego, Lina M; Quinn, David I; Hanna, Nasser H; Einhorn, Lawrence H; Albany, Costantine